Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
51.66
+0.65 (+1.27%)
Streaming Delayed Price
Updated: 11:17 AM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
29
30
Next >
2 Top Biotech Stocks to Buy Right Now
August 14, 2023
These drugmakers are among the most dominant in the world.
Via
The Motley Fool
Why Shares of MacroGenics Are Jumping Thursday
August 10, 2023
The company announced second-quarter earnings.
Via
The Motley Fool
Looking Into Sanofi's Recent Short Interest
August 08, 2023
Via
Benzinga
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
August 08, 2023
Tiziana Life Sciences, Inc.
Via
Benzinga
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon
August 03, 2023
Tiziana Life Sciences (NASDAQ: TLSA), a clinical-stage biotechnology company focused on developing immunotherapies, will soon announce the 6-month results for patients with non-active Secondary...
Via
Benzinga
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The Top Healthcare Stocks to Buy With $100
July 30, 2023
There's no need to have a fortune to invest in stocks.
Via
The Motley Fool
Sanofi (SNY) Q2 2023 Earnings Call Transcript
July 28, 2023
SNY earnings call for the period ending June 30, 2023.
Via
The Motley Fool
iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories
July 28, 2023
Bloomberg
Via
Benzinga
Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches
July 28, 2023
Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in
Via
Benzinga
US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon
July 28, 2023
Stocks appear to have shaken off Thursday's negativity and are positioned for a rebound on upbeat earnings.
Via
Benzinga
Sanofi's Earnings Outlook
July 27, 2023
Via
Benzinga
How Is The Market Feeling About Sanofi?
July 20, 2023
Via
Benzinga
Looking Into Sanofi's Recent Short Interest
July 03, 2023
Via
Benzinga
Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session
July 28, 2023
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Earnings Scheduled For July 28, 2023
July 28, 2023
Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion.
Via
Benzinga
Exscientia is the Sniper of the AI Drug Discovery Industry
July 27, 2023
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports
July 26, 2023
The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication and a weight loss...
Via
Benzinga
7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023
July 23, 2023
Even some of the top players of the market don’t get the attention they deserve, making these blue-chip stocks compelling.
Via
InvestorPlace
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
July 20, 2023
From
Recludix Pharma, Inc.
Via
GlobeNewswire
NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories
July 18, 2023
Wall Street Journal
Via
Benzinga
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
July 18, 2023
The FDA approved AstraZeneca Plc (NASDAQ:
Via
Benzinga
Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment
July 17, 2023
Tiziana Life Sciences (NASDAQ: TSLA) has presented data from its clinical trial showing that five of its six patients with an advanced stage of multiple sclerosis (MS) have shown a reduction in...
Via
Benzinga
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction
July 13, 2023
According to a survey conducted by U.S.
Via
Benzinga
Why Shares of Exscientia Jumped on Wednesday
July 12, 2023
The company may be riding the wave of an AI healthcare boom.
Via
The Motley Fool
Takeda Withdraws FDA Application For Dengue Vaccine Candidate On Data Disagreement
July 12, 2023
Takeda Pharmaceutical Co Ltd (NYSE: TAK) said on Tuesday that it was voluntarily
Via
Benzinga
Publications And Positive Data From Multiple Trials: Six Months In Review For Tiziana Life Sciences (NASDAQ: TLSA)
July 10, 2023
Tiziana Life Sciences (NASDAQ: TLSA) is a biotechnology company establishing itself in a cutting-edge position in the market with its breakt
Via
Benzinga
Evotec Secures US Government Contract For Orthopoxvirus Antibody
July 05, 2023
The U.S.
Via
Benzinga
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California
July 03, 2023
The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs.
Via
Benzinga
Sanofi's Amlitelimab Hits Primary Goal In Mid-Stage Atopic Dermatitis Study
June 27, 2023
Sanofi SA (NASDAQ: SNY) says its Phase 2b study (STREAM-AD) of amlitelimab for adults with moderate-to-severe atopic dermatitis, who cannot adequately manage their condition with topical medications,...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.